share_log

6-K: Transaction Notification

6-K: Transaction Notification

交易通知
美股SEC公告 ·  2024/10/11 10:58

Moomoo AI 已提取核心訊息

On October 10, 2024, multiple GSK executives and Persons Closely Associated (PCAs) acquired ordinary shares through dividend reinvestment under the Company's Share Reward Plan. The transactions were executed on the London Stock Exchange at £15.2563 and £15.3577 per share.Key participants included CEO Emma Walmsley (26 shares), President Corporate Development David Redfern (71 shares), CEO of ViiV Healthcare Deborah Waterhouse (58 shares), and Company Secretary Victoria Whyte (71 shares in total). Other executives including the Chief People Officer, Chief Commercial Officer, and various SVPs also participated in smaller volumes.Notable PCA transactions included Iain Whyte, PCA of Company Secretary Victoria Whyte, who acquired 1,105 shares at £15.3577, representing the largest single transaction in this dividend reinvestment event.
On October 10, 2024, multiple GSK executives and Persons Closely Associated (PCAs) acquired ordinary shares through dividend reinvestment under the Company's Share Reward Plan. The transactions were executed on the London Stock Exchange at £15.2563 and £15.3577 per share.Key participants included CEO Emma Walmsley (26 shares), President Corporate Development David Redfern (71 shares), CEO of ViiV Healthcare Deborah Waterhouse (58 shares), and Company Secretary Victoria Whyte (71 shares in total). Other executives including the Chief People Officer, Chief Commercial Officer, and various SVPs also participated in smaller volumes.Notable PCA transactions included Iain Whyte, PCA of Company Secretary Victoria Whyte, who acquired 1,105 shares at £15.3577, representing the largest single transaction in this dividend reinvestment event.
在2024年10月10日,多名GSk高管和緊密關聯人士(PCA)通過公司分享獎勵計劃以紅利再投資的方式購買了普通股。這些交易是在倫敦證券交易所以每股£15.2563和£15.3577的價格執行的。主要參與者包括首席執行官艾瑪·沃姆斯利(Emma Walmsley)(26股)、公司發展總裁大衛·雷德芬(David Redfern) (71股)、ViiV醫療公司首席執行官黛博拉·沃特豪斯(Deborah Waterhouse) (58股)以及公司秘書維多利亞·懷特(Victoria Whyte) (共71股)。其他高管包括首席人事官、首席商業官和多位高級副總裁也以較小的數量參與了此次交易。值得注意的PCA交易包括公司秘書維多利亞·懷特的PCA艾恩·懷特(Iain Whyte),他以£15.3577的價格購買了1,105股,成爲此次紅利再投資事件中最大的單一交易。
在2024年10月10日,多名GSk高管和緊密關聯人士(PCA)通過公司分享獎勵計劃以紅利再投資的方式購買了普通股。這些交易是在倫敦證券交易所以每股£15.2563和£15.3577的價格執行的。主要參與者包括首席執行官艾瑪·沃姆斯利(Emma Walmsley)(26股)、公司發展總裁大衛·雷德芬(David Redfern) (71股)、ViiV醫療公司首席執行官黛博拉·沃特豪斯(Deborah Waterhouse) (58股)以及公司秘書維多利亞·懷特(Victoria Whyte) (共71股)。其他高管包括首席人事官、首席商業官和多位高級副總裁也以較小的數量參與了此次交易。值得注意的PCA交易包括公司秘書維多利亞·懷特的PCA艾恩·懷特(Iain Whyte),他以£15.3577的價格購買了1,105股,成爲此次紅利再投資事件中最大的單一交易。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息